Luex Healthcare


Company Info

Celebrating 25 years of Trusted & Valued Healthcare

LUEX is an offspring from a family concern that has been operating successfully in the field of pharmaceutical logistics, distribution and marketing, particularly in dynamic emerging markets, since 1965.  LUEX itself was incorporated in London, England on 23rd April 1987.

For the past 25 years, such a heritage has made us a pharmaceutical company that is multi- faceted, versatile and thus sensitive to the ever changing needs of our trading partners. More significantly, our approach to ethical pharmaceutical healthcare, is shaped by our experience of working with major pharmaceutical multinational companies over several years. In collaborating with high profile corporate names such as PFIZER, ROCHE, BOOTS and MERCK to name but a few, we are privileged to have imbibed a distinguished business culture much to our credit.

For the past two decades, we have evolved towards offering a diverse and competitive portfolio of our own proprietary (Ethical and OTC) and generic medicines, contract manufactured in facilities compliant with the international standards of WHO and current Good Manufacturing Practice (GMP).

The product range consists predominantly of pharmaceuticals suitable to common tropical ailments and diseases, manufactured to the highest level of specifications in accordance with BP and USP standards.

In order to bolster its quality assurance and pharmacovigilance program, LUEX acquired an MHRA licence issued by the health authorities in the UK in 2002, and is well resourced to manage the Regulatory Affairs and Quality Control of its drugs.

On this premise, we ensure that the entire process of manufacturing, logistics, distribution and marketing of LUEX products, conforms to the highest ethical standards required in the field of medicine.  This, in turn, enables us to confidently serve a wide customer base, spanning from retail/wholesale pharmaceutical outlets, to private clinics, major hospitals and government health institutions.

Such facets have provided a springboard for the firm's natural progression into new product/market development, and local manufacturing in situ, thus opening up numerous opportunities for those whom it serves. Our most recent developments include the establishment of a state-of- the art current GMP Tablet/Capsule/Dry powder manufacturing plant in West Africa, and the launch of our product range in South America (2010) and Francofone Africa (2011).

2014 © Luex Healthcare. All rights reserved.